Serious Skin Reactions and COX-2 Inhibitors: a Case Series from Prescription-Event Monitoring (PEM) Studies in England

  • Layton, D.
  • Marshall, V.
  • Boshier, A.
  • Friedmann, P.
  • Shakir, S.A.W.

  • 1 Drug Safety Research Unit, Southampton, UK

    2 University of Portsmouth, Portsmouth, UK

    3 Dermatopharmacology Unit, Southampton General Hospital, Southampton, UK

Drug Safety 29(10):p 911-1010, 2006.
Copyright © 2006 Adis Data Information BV